{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:01:28Z","timestamp":1791907288306,"version":"4.3.4"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>Microglia performs a variety of functions during brain development designed to maintain brain homeostasis. Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed in microglial cells modulating phagocytosis, cytokine production, cell proliferation, and cell survival. Interestingly, the levels of soluble TREM2 (the secreted ectodomain of TREM2, sTREM2) were higher in cerebrospinal fluid (CSF) from Alzheimer's disease (AD) patients than subjects without cognitive decline. It is noteworthy that, while CSF sTREM2 levels have been extensively studied, few studies have investigated sTREM2 in blood producing conflicting results. We aimed to investigate the levels of sTREM2 in CSF and blood from a cohort of well-characterized AD comparing the results to those obtained in patients suffering from idiopathic normal pressure hydrocephalus (iNPH), a potentially reversible cognitive impairment. Our findings underlined a significantly lower plasma sTREM2 concentration in AD patients compared to iNPH subjects [39.1 ng\/mL (standard deviation (SD), 15.0) and 47.2 ng\/mL (SD, 19.5), respectively; <jats:italic>p<\/jats:italic> = 0.01], whereas no difference was revealed between the two groups in the CSF sTREM2 levels. The adjusted regression analyses evidenced in AD patients an association between plasma and CSF sTREM2 levels [<jats:italic>B<\/jats:italic> = 0.411; 95% confidence interval (CI), 0.137\u20130.685, <jats:italic>p<\/jats:italic> = 0.004], as well as \u03b2-amyloid concentrations (<jats:italic>B<\/jats:italic> = 0.035; 95% CI, 0.007\u20130.063, <jats:italic>p<\/jats:italic> = 0.01) and an association between CSF sTREM2 and phospho-Tau concentrations (<jats:italic>B<\/jats:italic> = 0.248; 95% CI, 0.053\u20130.443; <jats:italic>p<\/jats:italic> = 0.01). No significant relation was found in iNPH patients. In conclusion, these differences in sTREM2 profiles between AD and iNPH reinforce the notion that this receptor has a role in neurodegeneration.<\/jats:p>","DOI":"10.3389\/fmolb.2020.627931","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T05:49:31Z","timestamp":1615268971000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":34,"title":["The sTREM2 Concentrations in the Blood: A Marker of Neurodegeneration?"],"prefix":"10.3389","volume":"7","author":[{"given":"Evelyn","family":"Ferri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Dionigi","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Ciccone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Cesari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Arosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/14728222.2020.1738391","article-title":"Alzheimer's disease: microglia targets and their modulation to promote amyloid phagocytosis and mitigate neuroinflammation","volume":"24","author":"Anwar","year":"2020","journal-title":"Expert Opin. Ther. Targets"},{"key":"B2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13195-019-0545-5","article-title":"Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers","volume":"11","author":"Ashton","year":"2019","journal-title":"Alzheimers Res. Ther."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3233\/JAD-191254","article-title":"Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy","volume":"74","author":"Banerjee","year":"2020","journal-title":"J. Alzheimers Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jneuroim.2018.03.003","article-title":"Soluble TREM2 and biomarkers of central and peripheral inflammation in neurodegenerative disease","volume":"319","author":"Bekris","year":"2018","journal-title":"J. Neuroimmunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1038\/nn.3560","article-title":"TGF-beta signaling regulates neuronal C1q expression and developmental synaptic refinement","volume":"16","author":"Bialas","year":"2013","journal-title":"Nat. Neurosci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/ene.13583","article-title":"Increased expression of TREM2 in peripheral cells from mild cognitive impairment patients who progress into Alzheimer's disease","volume":"25","author":"Casati","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrn.2016.7","article-title":"TREM2 variants: new keys to decipher Alzheimer disease pathogenesis","volume":"17","author":"Colonna","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/j.cell.2018.05.003","article-title":"Disease-associated microglia: a universal immune sensor of neurodegeneration","volume":"173","author":"Deczkowska","year":"2018","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3233\/JAD-130581","article-title":"Distinguishing Alzheimer's disease from normal pressure hydrocephalus: a search for MRI biomarkers","volume":"38","author":"Di Ieva","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e0179280","DOI":"10.1371\/journal.pone.0179280","article-title":"Protein signature in cerebrospinal fluid and serum of Alzheimer's disease patients: the case of apolipoprotein A-1 proteoforms","volume":"12","author":"Fania","year":"2017","journal-title":"PLoS ONE"},{"key":"B12","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.mad.2019.01.005","article-title":"Apolipoprotein E gene in physiological and pathological aging","volume":"178","author":"Ferri","year":"2019","journal-title":"Mech. Ageing Dev."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2699","DOI":"10.1016\/j.neurobiolaging.2013.05.001","article-title":"Insights into TREM2 biology by network analysis of human brain gene expression data","volume":"34","author":"Forabosco","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.dadm.2016.12.002","article-title":"The APOE epsilon4 genotype modulates CSF YKL-40 levels and their structural brain correlates in the continuum of Alzheimer's disease but not those of sTREM2","volume":"6","author":"Gispert","year":"2017","journal-title":"Alzheimers Dement."},{"key":"B15","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13024-018-0298-9","article-title":"New insights into the role of TREM2 in Alzheimer's disease","volume":"13","author":"Gratuze","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"B16","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13195-016-0182-1","article-title":"Cerebrospinal fluid soluble TREM2 in aging and Alzheimer's disease","volume":"8","author":"Henjum","year":"2016","journal-title":"Alzheimers Res. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1111\/j.1471-4159.2009.06042.x","article-title":"A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia","volume":"109","author":"Hsieh","year":"2009","journal-title":"J. Neurochem."},{"key":"B21","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13024-017-0197-5","article-title":"TREM2 in neurodegenerative diseases","volume":"12","author":"Jay","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12974-017-0835-4","article-title":"The Alzheimer's disease risk factors apolipoprotein E and TREM2 are linked in a receptor signaling pathway","volume":"14","author":"Jendresen","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2949","DOI":"10.1038\/npp.2014.164","article-title":"Upregulation of TREM2 ameliorates neuropathology and rescues spatial cognitive impairment in a transgenic mouse model of Alzheimer's disease","volume":"39","author":"Jiang","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3233\/JAD-142622","article-title":"Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease","volume":"45","author":"Jingami","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.3390\/cancers11091315","article-title":"TREM2 acts as a tumor suppressor in colorectal carcinoma through Wnt1\/beta-catenin and Erk signaling","volume":"11","author":"Kim","year":"2019","journal-title":"Cancers"},{"key":"B26","doi-asserted-by":"publisher","first-page":"243r","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.neuron.2013.04.005","article-title":"Innate immunity in the CNS: redefining the relationship between the CNS and its environment","volume":"78","author":"Lampron","year":"2013","journal-title":"Neuron"},{"key":"B28","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41380-020-0760-2","article-title":"Cancer and Alzheimer's disease inverse relationship: an age-associated diverging derailment of shared pathways","volume":"26","author":"Lanni","year":"2020","journal-title":"Mol. Psychiatry."},{"key":"B29","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1038\/sj.mp.4002060","article-title":"Conformationally altered p53: a novel Alzheimer's disease marker?","volume":"13","author":"Lanni","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/j.neuron.2018.02.002","article-title":"Elevated TREM2 gene dosage reprograms microglia responsivity and ameliorates pathological phenotypes in Alzheimer's disease models","volume":"97","author":"Lee","year":"2018","journal-title":"Neuron"},{"key":"B31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.neulet.2018.08.038","article-title":"Soluble TREM2 changes during the clinical course of Alzheimer's disease: a meta-analysis","volume":"686","author":"Liu","year":"2018","journal-title":"Neurosci. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","article-title":"Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation","volume":"165","author":"Lui","year":"2016","journal-title":"Cell"},{"key":"B33","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s13024-020-00374-8","article-title":"Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study","volume":"15","author":"Ma","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"B34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/3-211-32318-X_48","article-title":"Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date","volume":"95","author":"Marmarou","year":"2005","journal-title":"Acta Neurochir."},{"key":"B35","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3390\/ijms19010318","article-title":"Microglia and aging: the role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes","volume":"19","author":"Mecca","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B36","doi-asserted-by":"publisher","first-page":"12540","DOI":"10.1038\/ncomms12540","article-title":"Microglia contact induces synapse formation in developing somatosensory cortex","volume":"7","author":"Miyamoto","year":"2016","journal-title":"Nat. Commun."},{"key":"B37","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.bcp.2014.01.008","article-title":"Microglial dysfunction in brain aging and Alzheimer's disease","volume":"88","author":"Mosher","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1083\/jcb.200808080","article-title":"TREM-2 (triggering receptor expressed on myeloid cells 2) is a phagocytic receptor for bacteria","volume":"184","author":"N'Diaye","year":"2009","journal-title":"J. Cell Biol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0197-4580(93)90100-P","article-title":"GFAP mRNA increases with age in rat and human brain","volume":"14","author":"Nichols","year":"1993","journal-title":"Neurobiol. Aging"},{"key":"B40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/ana.25385","article-title":"Serum soluble triggering receptor expressed on myeloid cells 2 as a biomarker for incident dementia: the hisayama study","volume":"85","author":"Ohara","year":"2019","journal-title":"Ann. Neurol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3233\/JAD-2010-1406","article-title":"Brain ventricular volume and cerebrospinal fluid biomarkers of Alzheimer's disease","volume":"20","author":"Ott","year":"2010","journal-title":"J. Alzheimers Dis."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain"},{"key":"B43","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12868-015-0161-7","article-title":"Expression and cellular localization of hepcidin mRNA and protein in normal rat brain","volume":"16","author":"Raha-Chowdhury","year":"2015","journal-title":"BMC Neurosci."},{"key":"B45","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"B46","doi-asserted-by":"publisher","first-page":"a020560","DOI":"10.1101\/cshperspect.a020560","article-title":"Microglia in health and disease","volume":"8","author":"Ransohoff","year":"2015","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.jamda.2018.11.014","article-title":"Repeated cerebrospinal fluid removal procedure in older patients with idiopathic normal pressure hydrocephalus ineligible for surgical treatment","volume":"20","author":"Rossi","year":"2019","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"B48","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/jnnp-2018-319148","article-title":"Inflammatory markers in Alzheimer's disease and mild cognitive impairment: a meta-analysis and systematic review of 170 studies","volume":"90","author":"Shen","year":"2019","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"B49","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers","volume":"8","author":"Suarez-Calvet","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1084\/jem.20041611","article-title":"Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2","volume":"201","author":"Takahashi","year":"2005","journal-title":"J. Exp. Med."},{"key":"B51","doi-asserted-by":"publisher","first-page":"13639","DOI":"10.1038\/s41598-018-31756-0","article-title":"Particular CSF sphingolipid patterns identify iNPH and AD patients","volume":"8","author":"Torretta","year":"2018","journal-title":"Sci. Rep."},{"key":"B52","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0092-8674(00)80564-4","article-title":"Cell death in development","volume":"96","author":"Vaux","year":"1999","journal-title":"Cell"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.cell.2015.01.049","article-title":"TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model","volume":"160","author":"Wang","year":"2015","journal-title":"Cell"},{"key":"B54","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.20141732","article-title":"TREM-2 promotes macrophage survival and lung disease after respiratory viral infection","volume":"212","author":"Wu","year":"2015","journal-title":"J. Exp. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.neuron.2014.01.043","article-title":"Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase","volume":"82","author":"Zhang","year":"2014","journal-title":"Neuron"},{"key":"B56","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1159\/000492596","article-title":"CD33 in Alzheimer's disease - biology, pathogenesis, and therapeutics: a mini-review","volume":"65","author":"Zhao","year":"2019","journal-title":"Gerontology"},{"key":"B57","doi-asserted-by":"publisher","first-page":"328","DOI":"10.3389\/fnagi.2019.00328","article-title":"The emerging roles and therapeutic potential of soluble TREM2 in Alzheimer's disease","volume":"11","author":"Zhong","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1084\/jem.20160844","article-title":"Soluble TREM2 induces inflammatory responses and enhances microglial survival","volume":"214","author":"Zhong","year":"2017","journal-title":"J. Exp. Med."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2020.627931\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T05:49:34Z","timestamp":1615268974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2020.627931\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":58,"alternative-id":["10.3389\/fmolb.2020.627931"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2020.627931","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"article-number":"627931"}}